vs
Side-by-side financial comparison of Natural Grocers by Vitamin Cottage, Inc. (NGVC) and ROGERS CORP (ROG). Click either name above to swap in a different company.
Natural Grocers by Vitamin Cottage, Inc. is the larger business by last-quarter revenue ($335.6M vs $200.5M, roughly 1.7× ROGERS CORP). Natural Grocers by Vitamin Cottage, Inc. runs the higher net margin — 3.4% vs 2.2%, a 1.1% gap on every dollar of revenue. On growth, ROGERS CORP posted the faster year-over-year revenue change (5.2% vs 1.6%). Natural Grocers by Vitamin Cottage, Inc. produced more free cash flow last quarter ($11.6M vs $1.1M). Over the past eight quarters, Natural Grocers by Vitamin Cottage, Inc.'s revenue compounded faster (4.4% CAGR vs -3.3%).
Natural Grocers by Vitamin Cottage, Inc. is a U.S.-based specialty retail chain that offers certified organic groceries, dietary supplements, natural personal care items, and eco-friendly household products. It serves health-conscious consumers across multiple U.S. states, following strict quality standards that exclude artificial preservatives, colors, flavors and harmful additives.
Rogers Corporation is a specialty engineered materials company headquartered in Chandler, Arizona.
NGVC vs ROG — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $335.6M | $200.5M |
| Net Profit | $11.3M | $4.5M |
| Gross Margin | 29.5% | 32.2% |
| Operating Margin | 4.4% | — |
| Net Margin | 3.4% | 2.2% |
| Revenue YoY | 1.6% | 5.2% |
| Net Profit YoY | 14.0% | 421.4% |
| EPS (diluted) | $0.49 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $200.5M | ||
| Q4 25 | $335.6M | $201.5M | ||
| Q3 25 | $336.1M | $216.0M | ||
| Q2 25 | $328.7M | $202.8M | ||
| Q1 25 | $335.8M | $190.5M | ||
| Q4 24 | $330.2M | $192.2M | ||
| Q3 24 | $322.7M | $210.3M | ||
| Q2 24 | $309.1M | $214.2M |
| Q1 26 | — | $4.5M | ||
| Q4 25 | $11.3M | $4.6M | ||
| Q3 25 | $11.8M | $8.6M | ||
| Q2 25 | $11.6M | $-73.6M | ||
| Q1 25 | $13.1M | $-1.4M | ||
| Q4 24 | $9.9M | $-500.0K | ||
| Q3 24 | $9.0M | $10.7M | ||
| Q2 24 | $9.2M | $8.1M |
| Q1 26 | — | 32.2% | ||
| Q4 25 | 29.5% | 31.5% | ||
| Q3 25 | 29.5% | 33.5% | ||
| Q2 25 | 29.9% | 31.6% | ||
| Q1 25 | 30.3% | 29.9% | ||
| Q4 24 | 29.9% | 32.1% | ||
| Q3 24 | 29.6% | 35.2% | ||
| Q2 24 | 29.2% | 34.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.4% | 3.5% | ||
| Q3 25 | 4.6% | 7.3% | ||
| Q2 25 | 4.7% | -33.3% | ||
| Q1 25 | 5.2% | -0.2% | ||
| Q4 24 | 4.0% | -6.6% | ||
| Q3 24 | 3.7% | 6.9% | ||
| Q2 24 | 4.2% | 5.3% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 3.4% | 2.3% | ||
| Q3 25 | 3.5% | 4.0% | ||
| Q2 25 | 3.5% | -36.3% | ||
| Q1 25 | 3.9% | -0.7% | ||
| Q4 24 | 3.0% | -0.3% | ||
| Q3 24 | 2.8% | 5.1% | ||
| Q2 24 | 3.0% | 3.8% |
| Q1 26 | — | $0.25 | ||
| Q4 25 | $0.49 | $0.20 | ||
| Q3 25 | $0.51 | $0.48 | ||
| Q2 25 | $0.50 | $-4.00 | ||
| Q1 25 | $0.56 | $-0.08 | ||
| Q4 24 | $0.43 | $-0.04 | ||
| Q3 24 | $0.38 | $0.58 | ||
| Q2 24 | $0.40 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.2M | $195.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $220.0M | $1.2B |
| Total Assets | $668.6M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $195.8M | ||
| Q4 25 | $23.2M | $197.0M | ||
| Q3 25 | $17.1M | $167.8M | ||
| Q2 25 | $13.2M | $157.2M | ||
| Q1 25 | $21.2M | $175.6M | ||
| Q4 24 | $6.3M | $159.8M | ||
| Q3 24 | $8.9M | $146.4M | ||
| Q2 24 | $13.9M | $119.9M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $220.0M | $1.2B | ||
| Q3 25 | $212.4M | $1.2B | ||
| Q2 25 | $202.5M | $1.2B | ||
| Q1 25 | $193.0M | $1.3B | ||
| Q4 24 | $181.9M | $1.3B | ||
| Q3 24 | $174.3M | $1.3B | ||
| Q2 24 | $167.8M | $1.3B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $668.6M | $1.4B | ||
| Q3 25 | $670.5M | $1.4B | ||
| Q2 25 | $659.0M | $1.5B | ||
| Q1 25 | $664.6M | $1.5B | ||
| Q4 24 | $648.9M | $1.5B | ||
| Q3 24 | $655.5M | $1.5B | ||
| Q2 24 | $654.4M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $21.1M | $5.8M |
| Free Cash FlowOCF − Capex | $11.6M | $1.1M |
| FCF MarginFCF / Revenue | 3.4% | 0.5% |
| Capex IntensityCapex / Revenue | 2.9% | 2.3% |
| Cash ConversionOCF / Net Profit | 1.86× | 1.29× |
| TTM Free Cash FlowTrailing 4 quarters | $42.6M | $70.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $5.8M | ||
| Q4 25 | $21.1M | $46.9M | ||
| Q3 25 | $15.6M | $28.9M | ||
| Q2 25 | $2.9M | $13.7M | ||
| Q1 25 | $34.1M | $11.7M | ||
| Q4 24 | $2.7M | $33.7M | ||
| Q3 24 | $24.5M | $42.4M | ||
| Q2 24 | $12.4M | $22.9M |
| Q1 26 | — | $1.1M | ||
| Q4 25 | $11.6M | $42.2M | ||
| Q3 25 | $7.5M | $21.2M | ||
| Q2 25 | $-4.2M | $5.6M | ||
| Q1 25 | $27.6M | $2.1M | ||
| Q4 24 | $-6.9M | $18.3M | ||
| Q3 24 | $18.0M | $25.2M | ||
| Q2 24 | $3.6M | $8.8M |
| Q1 26 | — | 0.5% | ||
| Q4 25 | 3.4% | 20.9% | ||
| Q3 25 | 2.2% | 9.8% | ||
| Q2 25 | -1.3% | 2.8% | ||
| Q1 25 | 8.2% | 1.1% | ||
| Q4 24 | -2.1% | 9.5% | ||
| Q3 24 | 5.6% | 12.0% | ||
| Q2 24 | 1.2% | 4.1% |
| Q1 26 | — | 2.3% | ||
| Q4 25 | 2.9% | 2.3% | ||
| Q3 25 | 2.4% | 3.6% | ||
| Q2 25 | 2.2% | 4.0% | ||
| Q1 25 | 1.9% | 5.0% | ||
| Q4 24 | 2.9% | 8.0% | ||
| Q3 24 | 2.0% | 8.2% | ||
| Q2 24 | 2.9% | 6.6% |
| Q1 26 | — | 1.29× | ||
| Q4 25 | 1.86× | 10.20× | ||
| Q3 25 | 1.32× | 3.36× | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 2.60× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 2.72× | 3.96× | ||
| Q2 24 | 1.35× | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
ROG
Segment breakdown not available.
